Dementia before Death in Ageing Societies— The Promise of Prevention and the Reality

Background Dementia and severe cognitive impairment are very closely linked to ageing. The longer we live the more likely we are to suffer from these conditions. Given population increases in longevity it is important to understand not only risk and protective factors for dementia and severe cognitive impairment at given ages but also whether protection affects cumulative risk. This can be explored by examining the effect on cumulative risk by time of death of factors found consistently to reduce risk at particular ages, such as education and social status. Methods and Findings In this analysis we report the prevalence of dementia and severe cognitive impairment in the year before death in a large population sample. In the Medical Research Council Cognitive Function and Ageing Study (a 10-y population-based cohort study of individuals 65 and over in England and Wales), these prevalences have been estimated by age, sex, social class, and education. Differences have been explored using logistic regression. The overall prevalence of dementia at death was 30%. There was a strong increasing trend for dementia with age from 6% for those aged 65–69 y at time of death to 58% for those aged 95 y and above at time of death. Higher prevalences were seen for severe cognitive impairment, with similar patterns. People with higher education and social class had significantly reduced dementia and severe cognitive impairment before death, but the absolute difference was small (under 10%). Conclusions Reducing risk for dementia at a given age will lead to further extension of life, thus cumulative risk (even in populations at lower risk for given ages) remains high. Ageing of populations is likely to result in an increase in the number of people dying with dementia and severe cognitive impairment even in the presence of preventative programmes. Policy development and research for dementia must address the needs of individuals who will continue to experience these conditions before death.

[1]  M. Dewey,et al.  The prevalence of dementia, depression and neurosis in later life: the Liverpool MRC-ALPHA Study. , 1993, International journal of epidemiology.

[2]  C. Brayne,et al.  Health and ill-health in the older population in England and Wales. The Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). , 2001, Age and ageing.

[3]  J. Copeland,et al.  Neuropsychological Diagnosis (GMS-HAS-AGECAT Package) , 1991, International Psychogeriatrics.

[4]  C. Brayne,et al.  Cognition and survival: an exploration in a large multicentre study of the population aged 65 years and over. , 2001, International journal of epidemiology.

[5]  A. Dobson,et al.  Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations , 2000, The Lancet.

[6]  T. Perls,et al.  Cognitive functional status of age-confirmed centenarians in a population-based study. , 2001, The journals of gerontology. Series B, Psychological sciences and social sciences.

[7]  J. Copeland,et al.  A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT , 1986, Psychological Medicine.

[8]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[9]  J. Guralnik,et al.  Patterns of functional decline at the end of life. , 2003, JAMA.

[10]  I. Higginson,et al.  Patterns of dying: palliative care for non-malignant disease. , 2004, Clinical medicine.

[11]  Laura Fratiglioni,et al.  Relation of education and occupation-based socioeconomic status to incident Alzheimer's disease. , 2004, American journal of epidemiology.

[12]  R. F. S. C. G. J. D. N. C. Worsham,et al.  Decline in deaths from heart disease and stroke--United States, 1900-1999. , 1999, MMWR. Morbidity and mortality weekly report.

[13]  C. Martyn,et al.  Usefulness of mortality data in determining the geography and time trends of dementia. , 1988, Journal of epidemiology and community health.

[14]  E. Mariani,et al.  Incidence and etiology of dementia in a large elderly Italian population , 2005, Neurology.

[15]  Cognitive function and dementia in six areas of England and Wales: the distribution of MMSE and prevalence of GMS organicity level in the MRC CFA Study. The Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). , 1998, Psychological medicine.

[16]  N. Day,et al.  Microalbuminuria, cardiovascular risk factors and cardiovascular morbidity in a British population: The EPIC-Norfolk Population-based Study , 2004, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[17]  J. Copeland,et al.  Dementia in centenarians , 2001, International journal of geriatric psychiatry.

[18]  Thomas Perls,et al.  Dementia-free centenarians , 2004, Experimental Gerontology.

[19]  A. Kalache,et al.  Active ageing: a policy framework. , 2003, Advances in gerontology = Uspekhi gerontologii.

[20]  DIW Coggon,et al.  Time and chance: the stochastic nature of disease causation , 2005, The Lancet.

[21]  Richard Schulz,et al.  End-of-life care and the effects of bereavement on family caregivers of persons with dementia. , 2003, The New England journal of medicine.

[22]  Kristine Yaffe,et al.  Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study , 2005, BMJ : British Medical Journal.

[23]  M. Dewey,et al.  Dementia, cognitive impairment and mortality in persons aged 65 and over living in the community: a systematic review of the literature , 2001, International journal of geriatric psychiatry.

[24]  H. Bickel [Need for nursing care by the elderly: results of a population based retrospective longitudinal study]. , 1996, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

[25]  C. Brayne,et al.  A systematic literature review of attrition between waves in longitudinal studies in the elderly shows a consistent pattern of dropout between differing studies. , 2005, Journal of clinical epidemiology.

[26]  Robert Luben,et al.  Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study , 2001, The Lancet.

[27]  N. Wareham,et al.  Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk) , 2001, BMJ : British Medical Journal.

[28]  C. Tomassini The demographic characteristics of the oldest old in the United Kingdom. , 2005, Population trends.

[29]  W F Forbes,et al.  Life expectancy and dementia in Canada: the Canadian study of health and aging. , 1997, Chronic diseases in Canada.

[30]  C. Brayne,et al.  Risk factors for incident dementia in England and Wales: The Medical Research Council Cognitive Function and Ageing Study. A population-based nested case-control study. , 2006, Age and ageing.

[31]  L. Poon,et al.  Cognitive functioning in centenarians: a coordinated analysis of results from three countries. , 2001, The journals of gerontology. Series B, Psychological sciences and social sciences.

[32]  M. Schroll,et al.  Stable stroke occurrence despite incidence reduction in an aging population: stroke trends in the danish monitoring trends and determinants in cardiovascular disease (MONICA) population. , 1999, Stroke.

[33]  C. Ritchie,et al.  A systematic review of the scientific evidence for the efficacy of a palliative care approach in advanced dementia , 2005, International Psychogeriatrics.

[34]  C. Brayne,et al.  The Incidence of Dementia in England and Wales: Findings from the Five Identical Sites of the MRC CFA Study , 2005, PLoS medicine.

[35]  Ian G. McKeith,et al.  Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales , 2001, The Lancet.